Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Aug 30;25(20):6098–6106. doi: 10.1158/1078-0432.CCR-19-0818

Table 4: Multivariable model for DFS based on clinical characteristics and baseline CXCL10.

A multivariable model was created to assess the additional predictive value of angiogenic factors and cytokines on DFS with reference to known prognostic factors used in the UISS score, including T-stage, Fuhrman grade, and ECOG performance status (Zisman et al 2002).

HR 95% CI p-value
T2 vs. T1 1.30 (0.70, 2.43) 0.41
T3 vs. T1 1.68 (0.95, 2.96) 0.072
T4 vs. T1 1.61 (0.21, 12.48) 0.65
Grade 2 vs. 1 0.91 (0.39, 2.14) 0.83
Grade 3 vs. 1 0.97 (0.42, 2.27) 0.95
Grade 4 vs. 1 1.65 (0.69, 3.94) 0.26
PS ≥ 1 vs. 0 1.16 (0.79, 1.70) 0.45
Baseline CXCL10 1.37 (1.13, 1.67) 0.002